Domača stranRHHBY • OTCMKTS
add
F. Hoffmann-La Roche
39,56 $
Po zaprtju:(0,00 %)0,00
39,56 $
Konec trgovanja: 18. okt., 16:00:28 GMT -4 · USD · OTCMKTS · Izjava
Prejšnji trg. dan.
39,09 $
Dnevni razpon
39,24 $ - 39,62 $
Letni razpon
29,20 $ - 42,43 $
Tržna kapitalizacija
258,79 mrd. USD
Povprečni obseg
1,49 mio.
Borzne novice
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (CHF) | jun. 2024info | Sprememba L/L |
|---|---|---|
Prihodek | 15,38 mrd. | 0,46 % |
Stroški poslovanja | 6,22 mrd. | 0,75 % |
Čisti dohodek | 3,13 mrd. | −12,32 % |
Čista dobičkovnost prihodkov | 20,35 | −12,70 % |
Earnings per share | — | — |
EBITDA | 6,17 mrd. | 1,01 % |
Efektivna davčna stopnja | 18,56 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (CHF) | jun. 2024info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 8,81 mrd. | 17,38 % |
Skupna sredstva | 95,79 mrd. | 13,53 % |
Skupne obveznosti | 62,91 mrd. | 16,44 % |
Celoten lastniški kapital | 32,88 mrd. | — |
Shares outstanding | 796,79 mio. | — |
Razmerje P/B | 1,08 | — |
Donosnost sredstev | 14,16 % | — |
Donosnost kapitala | 19,64 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (CHF) | jun. 2024info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 3,13 mrd. | −12,32 % |
Denar iz dejavnosti | 3,96 mrd. | 0,20 % |
Denar iz naložb | −1,43 mrd. | −494,40 % |
Denar iz financiranja | −2,72 mrd. | 34,29 % |
Neto sprememba denarnih sredstev | −276,00 mio. | 56,57 % |
Prost denarni tok | 3,19 mrd. | −2,82 % |
Vizitka
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021. Roche is one of the few companies increasing their dividend every year, for 2020 as the 34th consecutive year.
F. Wikipedia
Generalni direktor
Datum ustanovitve
1. okt. 1896
Sedež organizacije
Spletno mesto
Zaposleni
103.605
